Daclatasvir–sofosbuvir combo effective in chronic HCV infection

Research shows that the combination of daclatasvir and sofosbuvir leads to high rates of sustained virologic response in patients with chronic hepatitis C virus infection, including those who have not responded to previous therapy.
Source: MedWire News - Gastroenterology - Category: Gastroenterology Source Type: news